Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Daniels, J. M.
Right arrow Articles by Massey, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daniels, J. M.
Right arrow Articles by Massey, T. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 Oxford University Press

other

Biotransformation of aflatoxin B1 in rabbit lung and liver microsomes

Jonathan M. Daniels 1, Ling Liu 1, Richard K. Stewart 1 and Thomas E. Massey 1 2 3

1Departments of Pharmacology and Toxicology Queen's University. Kingston, Ontario. Canada K7L 3N6
2Department of Medicine Queen's University. Kingston, Ontario. Canada K7L 3N6

3To whom all correspondence should be addressed

Aflatoxin B1 (AFB1) is a potent hepatotoxic and hepato carcinogenic mycotoxin that requires bioactivation to AFB1 -2,3-oxide for activity. In addition to epoxidation, microsomal monooxygenases biotransform AFB1 to the less toxic metabolites, aflatoxin M1 (AFM1) and aflatoxin Q1 (AFQ1). The lung is at risk from AFB1 both via inhalation and via the circulation. In the present study, we have characterized rabbit lung and liver microsomal AFB1 binding (an index of AFB1-2,3-oxide formation), AFM1 formation and AFQ1 formation. Vmax values for AFB1–DNA binding were not different between lung and liver when expressed per mg microsomal protein (1.06 ± 0.13 and 2.12 ± 1.30 nmol/mg/h for lung and liver respectively), but lung values were greater than liver when expressed per mnol cytochrome P450 (3.64 ± 0.31 and 1.29 ± 0.70 nmol/nmol P450/h for lung and liver respectively). Km values for this reaction were not different between lung and liver. Vmax values for AFM1 formation in liver microsomes were greater than in lung when expressed per mg protein, but not when expressed per mnol P450. No differences were detected for the Km for AFM1 formation between lung and liver microsomes. For AFQ1 formation, no differences were detected between Vmax values of lung and liver, regardless of whether results were expressed per mg protein or per nmol P450, while the Km for AFQ1 formation was lower in liver. SKF-525A inhibited these reactions by 63–74% in lung microsomes and 90–96% in liver microsomes. These results indicate that the lung is capable of activating AFB and that rabbit lung microsomes contain high activity for this reaction. Furthermore, little AFM1 and AFQ1 are formed in lung microsomes, leading to minimal shunting of AFB1 from the activation pathway.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol SciHome page
T. R. Van Vleet, T. L. Watterson, P. J. Klein, and R. A. Coulombe Jr.
Aflatoxin B1 Alters the Expression of p53 in Cytochrome P450-Expressing Human Lung Cells
Toxicol. Sci., February 1, 2006; 89(2): 399 - 407.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. B. J. Smith, P. A. Harper, J. M. Y. Wong, M. S. M. Lam, K. R. Reid, D. Petsikas, and T. E. Massey
Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms
Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 839 - 853.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. K. Stewart, G. B.J. Smith, P. J. Donnelly, K. R. Reid, D. Petsikas, A.A. Conlan, and T. E. Massey
Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in human lung: differential cellular distribution and lack of significance of the GSTM1 genetic polymorphism
Carcinogenesis, October 1, 1999; 20(10): 1971 - 1977.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.